Evolus Inc (EOLS)
12.74
-0.01
(-0.08%)
USD |
NASDAQ |
May 13, 12:23
Evolus Profit Margin (Quarterly): -22.09% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -22.09% |
| December 31, 2023 | -19.40% |
| September 30, 2023 | -33.83% |
| June 30, 2023 | -36.76% |
| March 31, 2023 | -35.45% |
| December 31, 2022 | -30.16% |
| September 30, 2022 | -59.81% |
| June 30, 2022 | -63.16% |
| March 31, 2022 | -51.61% |
| December 31, 2021 | -52.45% |
| Date | Value |
|---|---|
| September 30, 2021 | -72.85% |
| June 30, 2021 | -59.78% |
| March 31, 2021 | 52.29% |
| December 31, 2020 | -538.0% |
| September 30, 2020 | -64.88% |
| June 30, 2020 | -270.6% |
| March 31, 2020 | -188.0% |
| December 31, 2019 | -74.60% |
| September 30, 2019 | -204.9% |
| June 30, 2019 | -1.63K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.63K%
Minimum
Jun 2019
52.29%
Maximum
Mar 2021
-172.6%
Average
-59.80%
Median
Profit Margin (Quarterly) Benchmarks
| Viatris Inc | 3.11% |
| Shockwave Medical Inc | 25.29% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.76% |
| Xtant Medical Holdings Inc | -15.31% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -32.88% |
| Return on Invested Capital | -62.33% |
| Gross Profit Margin (Quarterly) | 69.55% |
| Operating Margin (Quarterly) | -12.38% |
| Return on Net Operating Assets | -47.79% |